One of the most frequently investigated hypothesis of the pathophysiology underlying Seasonal Affective Disorder(SAD) or so called winterdepression is a disturbance of circadian rhythms. Since the circadian system is especially sensitive for the blue portion of the light spectrum, a new light therapy device with more blue light (blue enriched polychromatic light) was tested for its efficacy to treat SAD. In chronobiological terms this light is hypothesized to be more potent in inducing non-visual effects. In the present study fluorescent tubes that emit a high portion of short wavelength light on top of the normal wavelengths are tested for its superiority in treating SAD. This blue-enriched light (colour temperature 17000 ºK) is compared to standard light treatment (5000 º K) in SAD patients., The investigators hypothesise that blue- enriched light improve the therapeutic effects of light treatment leading to a higher response or the same response in a shorter time schedule compared to standard light treatment.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
52
9000 lux, 30 minutes in the morning
9000 lux 20 minutes in the morning
9000 lux 30 minutes in the morning
Department of Psychiatry, University Medical Center Groningen
Groningen, Netherlands
SIGH SAD depression observer rating
Time frame: days 1, 8, 15, 22
selfrating of depressive mood
Time frame: once daily during 22 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.